Delivery Order SPE2DB22D2218-SPE2DB24FR2QS
Award Date
5/23/24
Potential Completion Date
5/24/24
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of XELJANZ 5 MG TABLET UU 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 27, 2025, with a ceiling value of $7,053.98 and an ultimate completion date of February 28, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This federal contract award is for the delivery of XELJANZ 5 MG TABLET, a prescription medication, to the Defense Logistics Agency (DLA). The $12,278.75 firm fixed-price contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 11, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,534.14 and is a firm fixed-price delivery order with an ultimate completion date of December 12, 2024. This contract is not designated as a set-aside and is part of...
This federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $27,152.82 and a completion date of December 30, 2024. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen...
This federal contract award is for the delivery of 4566199195 XELJANZ XR 11 MG TABLET UU 30S, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,446.74 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 24, 2024, with an ultimate completion date of October 25, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This federal contract award is for the delivery of XELJANZ 5 MG tablets to the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. The contract was awarded to the Amerisourcebergen Drug Corporation, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract is a Delivery Order with a Firm Fixed Price of $2,839.84 and a completion date...
This federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,773.65 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 11, 2025, with a completion date of February 12, 2025. The contract is a delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of pharmaceutical products, specifically the drug XELJANZ 5 MG TABLET, to the Defense Logistics Agency (DLA). The $3,722.97 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a pharmaceutical distribution company. The contract has a ceiling value of $3,722.97 and an ultimate completion date of February 23, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent...
This federal contract award is for the delivery of XELJANZ 5 MG TABLET (NDC 00069-0501-60) from Amerisourcebergen Drug Corp to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $4,473.51, has a period of performance through May 24, 2024. The contract is not set aside for any specific business type. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor on this award, which is part of a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,312.76, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price, and the ultimate completion date is December 3, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...